Astera Labs (NASDAQ:ALAB) Research Coverage Started at Citigroup

Citigroup initiated coverage on shares of Astera Labs (NASDAQ:ALAB) in a research note published on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $200.00 price objective on the stock.

ALAB has been the subject of several other reports. Weiss Ratings lowered shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Barclays set a $165.00 price target on shares of Astera Labs in a research report on Thursday, January 15th. Loop Capital started coverage on shares of Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. Northland Securities upped their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $199.44.

Astera Labs Price Performance

NASDAQ ALAB opened at $117.14 on Thursday. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The company has a market capitalization of $20.06 billion, a PE ratio of 96.02, a P/E/G ratio of 2.31 and a beta of 1.78. The company has a fifty day moving average of $131.56 and a 200 day moving average of $159.09.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period last year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Research analysts expect that Astera Labs will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, Director Jack R. Lazar sold 2,500 shares of the business’s stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $130.00, for a total transaction of $325,000.00. Following the completion of the sale, the director owned 84,851 shares of the company’s stock, valued at $11,030,630. The trade was a 2.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jitendra Mohan sold 157,500 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $131.58, for a total transaction of $20,723,850.00. Following the completion of the transaction, the chief executive officer directly owned 4,531,732 shares in the company, valued at $596,285,296.56. This represents a 3.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 577,292 shares of company stock worth $69,495,249 in the last ninety days. Company insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after purchasing an additional 1,693,918 shares in the last quarter. Atreides Management LP lifted its holdings in Astera Labs by 2,496.6% in the 4th quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock valued at $268,038,000 after purchasing an additional 1,549,144 shares in the last quarter. Amundi boosted its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC acquired a new stake in Astera Labs during the 3rd quarter worth $209,599,000. Finally, BNP Paribas Financial Markets grew its holdings in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Citi initiated/maintained a Buy and set a $200 price target on ALAB, highlighting PCIe and AI-infrastructure opportunity — a sizable analyst endorsement that can lift sentiment and buying interest. Benzinga Coverage
• Positive Sentiment: Research notes (TipRanks summary) underscore Astera Labs’ PCIe switch leadership and positioning in rack-scale AI connectivity, framing multiyear revenue upside tied to data-center AI buildouts. Astera Labs: Leveraging PCIe Switch Leadership…
• Positive Sentiment: Astera appears on roundups of leading growth stocks with notable insider ownership — a signal some investors use to judge management alignment and conviction, which can support valuation multiple expansion if execution continues. April 2026’s Leading Growth Stocks With Insider Ownership
• Neutral Sentiment: Company announced it will report Q1 2026 results after market close on May 5 and hold a conference call — an imminent catalyst that could swing the stock depending on revenue, margins and guidance. Astera Labs Announces Conference Call…
• Negative Sentiment: Recent articles flag a ~36% YTD decline and call out margin pressure and intensifying competition as key near-term risks; these concerns help explain the share-price pullback despite top-line AI/PCIe tailwinds. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD?
• Negative Sentiment: Analyst commentary and newsletter pieces emphasize margin compression risks even as demand grows — if margins miss or competition accelerates, upside expectations tied to AI/PCIe could be delayed. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD? (Zacks)

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.